First Time Loading...

Chugai Pharmaceutical Co Ltd
TSE:4519

Watchlist Manager
Chugai Pharmaceutical Co Ltd Logo
Chugai Pharmaceutical Co Ltd
TSE:4519
Watchlist
Price: 5 094 JPY 1.35% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Chugai Pharmaceutical Co Ltd

Wall Street analysts forecast Chugai Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Chugai Pharmaceutical Co Ltd is 6 241.47 JPY with a low forecast of 4 545 JPY and a high forecast of 7 780.5 JPY.

Lowest Forecast
Wall Street Target
4 545 JPY
11% Downside
Average Forecast
Wall Street Target
6 241.47 JPY
23% Upside
Highest Forecast
Wall Street Target
7 780.5 JPY
53% Upside
Lowest
Price Target
4 545 JPY
11% Downside
Average
Price Target
6 241.47 JPY
23% Upside
Highest
Price Target
7 780.5 JPY
53% Upside
Chugai Pharmaceutical Co Ltd Competitors:
Price Targets
LAURUSLABS
Laurus Labs Ltd
15% Downside
NKTR
Nektar Therapeutics
30% Upside
SUPN
Supernus Pharmaceuticals Inc
34% Upside
C
CU6
Clarity Pharmaceuticals Ltd
6% Downside
LAURUSLABS
Laurus Labs Ltd
15% Downside
NKTR
Nektar Therapeutics
30% Upside
SUPN
Supernus Pharmaceuticals Inc
34% Upside
C
CU6
Clarity Pharmaceuticals Ltd
6% Downside
2348
Dawnrays Pharmaceutical (Holdings) Ltd
133% Upside
AARTIDRUGS
Aarti Drugs Ltd
13% Upside
Z
002332
Zhejiang Xianju Pharmaceutical Co Ltd
33% Upside

Revenue
Forecast

Revenue Estimate
Chugai Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Chugai Pharmaceutical Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 2%.

11%
Past Growth
2%
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Chugai Pharmaceutical Co Ltd

Operating Income forecast
is not available for
Chugai Pharmaceutical Co Ltd

Net Income
Forecast

Net Income Estimate
Chugai Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Chugai Pharmaceutical Co Ltd's net income is 23%. The projected CAGR for the next 3 years is 7%.

23%
Past Growth
7%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Chugai Pharmaceutical Co Ltd's stock price target?
Price Target
6 241.47 JPY

According to Wall Street analysts, the average 1-year price target for Chugai Pharmaceutical Co Ltd is 6 241.47 JPY with a low forecast of 4 545 JPY and a high forecast of 7 780.5 JPY.

What is Chugai Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
2%

For the last 8 years the compound annual growth rate for Chugai Pharmaceutical Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 2%.

What is Chugai Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Chugai Pharmaceutical Co Ltd's net income is 23%. The projected CAGR for the next 3 years is 7%.

ALPHA SPREAD
Join more than 134,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.